EpiMix Based Novel Vaccine Candidate for <i>Shigella</i>: Evidence of Prophylactic Immunity in Balb/c Mice.

EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice.

Padh, Harish; Yagnik, Bhrugu; Sharma, Drashya; Desai, Priti.

Afiliação

Padh H; Sardar Patel University, Vallabh Vidyanagar, Gujarat 388120 India.
Yagnik B; Department of Cell and Molecular Biology, B.V. Patel Pharmaceutical Education and Research Development (PERD) Centre, Ahmedabad, Gujarat 380054 India.
Sharma D; BRD School of Bioscience, Sardar Patel University, Vallabh Vidyanagar, Gujarat 388120 India.
Desai P; Department of Cell and Molecular Biology, B.V. Patel Pharmaceutical Education and Research Development (PERD) Centre, Ahmedabad, Gujarat 380054 India.

Int J Pept Res Ther ; 27(2): 1095-1110, 2021.

Article em En | MEDLINE | ID: mdl-33551691